• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Medtronic’s board OKs $5B stock buyback, raises dividend 7%

Medtronic’s board OKs $5B stock buyback, raises dividend 7%

June 23, 2017 By Brad Perriello

Medtronic logoThe board of directors at Medtronic (NYSE:MDT) OK’d a $5 billion stock buyback program today and raised the medical device maker’s dividend payout by 7%.

The new repurchasing program supersedes a 2015 plan to reacquire 80 million shares, or about 6% of the total at that time.

Today Medtronic said it’s also raising its dividend to 46¢ per share, representing an annual dividend of $1.84 per share. The dividend-per-share payout ratio is 40% of last year’s adjusted earnings per share of $4.60, the company said.

It’s the 40th consecutive dividend increase, which including today’s boost grew at a 17% compounded annual rate during those years.

“Today’s increase in our dividend demonstrates the confidence of the board and our management team in the strength of the company’s cash flow generation and the ability to generate value for our shareholders,” chairman & CEO Omar Ishrak said in prepared remarks. “We are committed to returning a minimum of 50% of our free cash flow each year through dividends and share repurchases, balancing the return of cash to our shareholders with disciplined reinvestment in our business to drive sustainable growth.”

Early last year Medtronic revealed its plan for spending a $9.3 billion windfall from its $50 billion acquisition of Covidien, including a $5 billion share buyback by the end of April 2018.

Fridley, Minn.-based Medtronic said at the time that it planned to use most of the balance after the stock buyback to pay down debt, seeking to regain its A credit rating. The company committed to returning at least 50% of the $9.3 billion to shareholders, either through dividends or buybacks.

Filed Under: Wall Street Beat Tagged With: Medtronic

More recent news

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • Ancora Heart reaches enrollment milestone in pivotal heart failure device trial
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Johnson & Johnson launches daily disposable multifocal toric contact lens
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy